Form 4 Tracker
Ivan Hyep

Chief Financial Officer · 5 filings · Latest: Apr 21, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Ivan HyepChief Financial OfficerApr 21, 2026
Sale
$23.009,200$211.6K145,355
BCAX
Ivan HyepChief Financial OfficerApr 21, 2026
Option Exercise
$3.799,200$34.9K154,555
BCAX
Hyep IvanApr 21, 2026
Proposed Sale
$23.189,200$213.2K
BCAX
Ivan HyepChief Financial OfficerMar 23, 2026
Sale
$18.529,200$170.3K145,355
BCAX
Ivan HyepChief Financial OfficerMar 23, 2026
Option Exercise
$3.799,200$34.9K154,555
BCAX
Hyep IvanMar 23, 2026
Proposed Sale
$18.609,200$171.1K
BCAX
Ivan HyepChief Financial OfficerMar 4, 2026
Sale
$18.252,963$54.1K145,355
BCAX
Ivan HyepChief Financial OfficerMar 4, 2026
Option Exercise
$3.792,963$11.2K148,318
BCAX
Ivan HyepChief Financial OfficerMar 3, 2026
Sale
$18.2213,555$246.9K145,355
BCAX
Ivan HyepChief Financial OfficerMar 3, 2026
Option Exercise
$3.7913,555$51.4K158,910
BCAX
Hyep IvanMar 4, 2026
Proposed Sale
$18.252,963$54.1K
BCAX
Hyep IvanMar 3, 2026
Proposed Sale
$18.2213,555$246.9K
BCAX
Ivan HyepChief Financial OfficerJan 22, 2026
Sale
$18.151,882$34.2K145,355
BCAX
Ivan HyepChief Financial OfficerJan 22, 2026
Option Exercise
$3.791,882$7.1K147,237
BCAX
Hyep IvanJan 22, 2026
Proposed Sale
$18.151,882$34.2K
BCAX
Hyep IvanDec 22, 2025
Proposed Sale
$17.879,200$164.4K
BCAX
Hyep IvanNov 24, 2025
Proposed Sale
$18.5517,795$330.1K
BCAX
Hyep IvanNov 21, 2025
Proposed Sale
$18.15605$11.0K
BCAX
Hyep IvanOct 9, 2025
Proposed Sale
$17.896,415$114.8K
BCAX
Hyep IvanOct 8, 2025
Proposed Sale
$18.175,627$102.2K

Page 1 of 2

Next →